The Fund Grade · free · no account needed
What grade does MTCAX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
MFS Technology Fund - Class A
#17 of 500 graded active funds · blend · large segment peer group
The point · specialist footprint
MTCAX puts more of its book behind proven specialists than 99% of graded funds.
Bottom 20%
Bottom 40%
Middle
Top 40%
● Top 20%
That has mattered: over the past 2.7 years, funds on this rung beat bottom-rung funds by about 3.8% per quarter, and beat the S&P in 43% of fund-quarters versus their 22%. The evidence argues this fund earns its seat.
10,000+ funds tracked · the graded specialists among them drive every read
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
MTCAX vs the Honor Roll · share card ↗Conviction exposure
68.2%
of the book in specialist-converged names
Late-stage weight
17.4%
of the book in Crowded or Fading names
Active share
87.2%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
MTCAX earns an A grade and ranks 17 out of 500 graded funds, with 68.2% of assets held by specialist investors whose footprint sits in the top 20% of peers. The early positions in ORCL, KLAC, and STX are where specialists are still building conviction, but AVGO at 8.7% weight is fading, which is the single biggest risk to watch.
→ Monitor AVGO closely. At 8.7% of the fund, specialist selling there could weigh meaningfully on returns.
→ The early Emerging stakes in ORCL, KLAC, and STX suggest the fund has genuine upside if those positions play out.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.